Systematic Reviews of Treatments for Pneumonia

Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for pneumonia.

Reviewed February 2009

Printer friendly page

14 Resources Found
Results 1 to 14 displayed.
Title:   Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Ventilator-associated pneumonia (VAP) is a condition which occurs in patients mechanically-ventilated for more than 48 hours and can significantly increase the mortality of ICU patients. The best method of diagnosing VAP and identifying the causative or...
Date:   Feb 2008
Title:   Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Infected purulent pleural effusions (empyema) with isolated collections (loculations) of fluid or pus (complicated parapneumonic effusions) may develop with pneumonia. Drainage of this infected fluid via an intercostal catheter is important in healing. ...
Date:   Jan 2008
Title:   Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Agents which cause pneumonia are traditionally divided into 'typical' and 'atypical', each dictating a distinct antibiotic treatment. Atypical agents refer to certain bacteria - namely, Legionella pneumophila (L. pneumophila), Mycoplasma pneumoniae (M. ...
Date:   Nov 2007
Title:   Azithromycin for acute lower respiratory tract infections
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Acute lower respiratory tract infections (LRTI) are one of the most common diagnoses in ambulatory settings. In general, people with LRTI present with cough and fever, which varies from mild to severe. Antibiotic therapy is considered in patients with a...
Date:   Oct 2007
Title:   Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Pneumonia is a major cause of mortality in children under five years of age. Treatment of pneumonia requires the use of an effective antibiotic in adequate doses for an appropriate duration. In most cases, treatment ranges between 7 and 14 days, but thi...
Date:   Sep 2007
Title:   Vaccines for preventing pneumococcal infection in adults
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Streptococcus pneumoniae is responsible for illness and death in adults worldwide, usually from pneumonia and less often from invasive pneumococcal disease (IPD). Vaccination (using pneumococcal polysaccharide vaccine (PPV)) in different populations mi...
Date:   Sep 2007
Title:   Closed tracheal suction systems versus open tracheal suction systems for mechanically ventilated adult patients
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   The comparison of open and closed suction systems shows them to have similar results in terms of safety and effectiveness....
Date:   Aug 2007
Title:   Vitamin A for non-measles pneumonia in children
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Acute respiratory infections, mostly in the form of pneumonia, are the leading cause of death in children under five years of age living in low income countries. Vitamin A supplementation has been found to reduce mortality and the severity of respirator...
Date:   Aug 2007
Title:   Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Over-the-counter (OTC) medications, including mucolytics and antitussives, are commonly used by patients and recommended by healthcare staff as adjuncts in the treatment of pneumonia. In this review we found insufficient evidence to draw any conclusions...
Date:   Jul 2007
Title:   Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Pneumocystis jirovecii is a fungus causing pneumonia mainly among patients with an impaired immune system, such as those infected with the human immunodeficiency virus (HIV), cancer patients, following organ transplantation, patients receiving immune su...
Date:   May 2007
Title:   Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Pneumonia, or infection involving the lungs, is responsible for a significant number of deaths worldwide. Pneumonia is especially life-threatening in older people and people with other illnesses that may affect the immune system (such as diabetes). In a...
Date:   Jan 2007
Title:   Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract infection in infants. Ribavirin is an expensive antiviral drug that has been used to treat RSV infections. It is the only drug currently available, but there are ongoing conc...
Date:   Nov 2006
Title:   Antibiotics for community acquired pneumonia in adult outpatients
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Pneumonia, or infection involving the lungs, is responsible for a significant number of deaths worldwide. Pneumonia is especially life-threatening in older people and people with other illnesses that may affect the immune system (such as diabetes). Anti...
Date:   Feb 2004
Title:   Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   People who need ventilation (mechanical breathing support) in intensive care can develop respiratory tract infections or pneumonia (a lung infection). Some people will die because of these infections. The review of trials found that a combination of ant...
Date:   Nov 2003
Results 1 to 14 displayed.

  • Other Related Topics: